In the case of butein, a dose-dependent reduction in COX-2 and Matrix metalloproteinase-9 (MMP-9) expression in oral squamous cell carcinoma lines (SAS and KB) was observed [81]. Here, MMP9 is linked to oral cavity squamous cell carcinoma.